Skip to main content
. 2020 Sep 8;30(9):1254–1262. doi: 10.1089/thy.2019.0269

Table 6.

Response Evaluation Criteria in Solid Tumors Tumor Response Rates by Presence/Absence of Specific Mutations

Clinical response by subgroups (patients with mutational interrogation only)
Histological subtype
 Follicular 0/2 (0%)
 Hürthle cell 2/6 (33.3%)
 Papillary 2/8 (25.0%)
BRAF mutation
 Yes 1/5 (20.0%)
 No 3/11 (27.3%)
BRAF or HRAS mutation
 Yes 2/7 (28.6%)
 No 2/9 (22.2%)
TP53 mutation
 Yes 0/3 (0%)
 No 4/13 (30.8%)